Carregant...
Roadblocks to success for RNA CARs in solid tumors
While CAR therapy has begun to demonstrate efficacy, cell-engineering techniques that result in permanent genomic modification carry several safety concerns. CAR expression driven by RNA creates a platform for delivery of highly-active cell therapy while avoiding long-term CAR-driven toxicity. Using...
Guardat en:
| Publicat a: | Oncoimmunology |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4353174/ https://ncbi.nlm.nih.gov/pubmed/25964863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.962974 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|